Background. Intrahepatic cholangiocarcinoma (iCCA) is a contraindication to liver
transplantation in most centers worldwide. Therefore, only a few such cases have been …

The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

Liver resection (LR) is the only recommended effective curative treatment for patients with
intrahepatic cholangiocarcinoma (ICC), but the prognosis of patients with ICC is still poor …

The indication of liver transplantation for intrahepatic cholangiocarcinoma (ICC) is highly
controversial. Initially, liver transplantation was embraced as a promising treatment for ICC …

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is not a widely accepted indication
for orthotopic liver transplantation (OLT). The present study describes our institutional …

Background At present, intrahepatic cholangiocarcinoma is a contraindication for liver
transplantation. However, previous studies in this field did not preselect patients on the basis …

Cholangiocarcinoma (CCA) arises from the biliary tract epithelium and accounts for 10–15%
of all hepatobiliary malignancies. Depending on anatomic location, CCA is classified as …

Although hepatocellular carcinoma (HCC) has become a common indication for liver
transplantation (LT), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular …

Background Liver transplantation offers a potential for curative-intent treatment in patients
presenting with non-metastatic intrahepatic cholangiocarcinoma that is not amenable to …